Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Druckformat: 0893-9675
ISSN Online: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2013007784
pages 435-448

Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer

Suzy V. Torti
Departments of Molecular, Microbial & Structural Biology; UCONN Health Center, Farmington, CT
Frank M. Torti
Internal Medicine, University of Connecticut Health Center, Farmington, CT

ABSTRAKT

Despite many recent advances, breast cancer remains a clinical challenge. Current issues include improving prognostic evaluation and increasing therapeutic options for women whose tumors are refractory to current frontline therapies. Iron metabolism is frequently disrupted in breast cancer, and may offer an opportunity to address these challenges. Iron enhances breast tumor initiation, growth and metastases. Iron may contribute to breast tumor initiation by promoting redox cycling of estrogen metabolites. Up-regulation of iron import and down-regulation of iron export may enable breast cancer cells to acquire and retain excess iron. Alterations in iron metabolism in macrophages and other cells of the tumor microenvironment may also foster breast tumor growth. Expression of iron metabolic genes in breast tumors is predictive of breast cancer prognosis. Iron chelators and other strategies designed to limit iron may have therapeutic value in breast cancer. The dependence of breast cancer on iron presents rich opportunities for improved prognostic evaluation and therapeutic intervention.

SCHLÜSSELWÖRTER: iron, breast cancer, estrogen

Articles with similar content:

Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy
Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 2
Atul K. Tiwari, Naveen K. Vishvakarma, Dhananjay Shukla, Sapnita Shinde, Saurabh Saxena, Vineeta Dixit
Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
Devasis Chatterjee, Austin DeChalus, Peter J. Quesenberry, Andrew R. Mendelsohn, Joseph F. Renzulli II, Justin Q. Wang, Giovanni Camussi, Devin N. Chatterjee, Atsushi Mizokami, Evan T. Keller
Liquid Biopsies for Assessing Metastatic Melanoma Progression
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 1-2
Dave S.B. Hoon, Kelly Huynh
Iron Chelation: Inhibition of Key Signaling Pathways in the Induction of the Epithelial Mesenchymal Transition in Pancreatic Cancer and Other Tumors
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 5
Alexander Richardson, Des R. Richardson, Zaklina Kovacevic
Phytochemicals Targeting Colorectal Cancer Growth and Metastasis
Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 2
Santoshi Muppala